Photo from wikipedia
586 Research Letters rebounding in the summer of 2021, after clinics resumed routine screening. However, the pandemic’s impact on lung cancer screening (LCS) rates nationally or by state is not… Click to show full abstract
586 Research Letters rebounding in the summer of 2021, after clinics resumed routine screening. However, the pandemic’s impact on lung cancer screening (LCS) rates nationally or by state is not yet known. This is of interest because lung cancer remains the leading cause of cancer death in the United States, and annual LCS with low-dose CT scanning (LDCT) is recommended for a group that is at a high risk of dying of this disease. The objective in the current study was to examine annual LCS rates before (2019) and during (2020) the pandemic nationally and according to state.
Journal Title: Chest
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!